J. Ravits, L. Spada, and A. , ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration, Neurology, vol.73, issue.10, pp.805-811, 2009.
DOI : 10.1212/WNL.0b013e3181b6bbbd

P. Pradat, G. Bruneteau, P. Gordon, L. Dupuis, and D. Bonnefont-rousselot, Impaired glucose tolerance in patients with amyotrophic lateral sclerosis, Amyotroph Lateral Scler, pp.1-6, 2009.

J. Desport, P. Preux, L. Magy, Y. Boirie, and J. Vallat, Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis, Am J Clin Nutr, vol.74, pp.328-334, 2001.

J. Desport, P. Preux, T. Truong, J. Vallat, and D. Sautereau, Nutritional status is a prognostic factor for survival in ALS patients, Neurology, vol.53, issue.5, pp.1059-1063, 1999.
DOI : 10.1212/WNL.53.5.1059
URL : https://hal.archives-ouvertes.fr/hal-01083608

B. Funalot, J. Desport, F. Sturtz, W. Camu, and P. Couratier, High metabolic level in patients with familial amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis, vol.5, issue.2, pp.1-5, 2008.
DOI : 10.1212/WNL.53.5.1059
URL : https://hal.archives-ouvertes.fr/hal-00338315

L. Dupuis, P. Corcia, A. Fergani, J. Gonzalez-de-aguilar, and D. Bonnefont-rousselot, Dyslipidemia is a protective factor in amyotrophic lateral sclerosis, Neurology, vol.70, issue.13, pp.1004-1009, 2008.
DOI : 10.1212/01.wnl.0000285080.70324.27

C. Heckman, C. Mottram, K. Quinlan, R. Theiss, and J. Schuster, Motoneuron excitability: The importance of neuromodulatory inputs, Clinical Neurophysiology, vol.120, issue.12, 2009.
DOI : 10.1016/j.clinph.2009.08.009

J. Rekling, G. Funk, D. Bayliss, X. Dong, and J. Feldman, Synaptic control of motoneuronal excitability, Physiol Rev, vol.80, pp.767-852, 2000.

R. Sandyk, SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS, International Journal of Neuroscience, vol.82, issue.2, pp.775-826, 2006.
DOI : 10.1016/0306-4522(85)90225-8

O. Bertel, S. Malessa, E. Sluga, and O. Hornykiewicz, Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord, Brain Research, vol.566, issue.1-2, pp.54-60, 1991.
DOI : 10.1016/0006-8993(91)91680-Y

V. Forrest, P. Ince, M. Leitch, E. Marshall, and P. Shaw, Serotonergic neurotransmission in the spinal cord and motor cortex of patients with motor neuron disease and controls: quantitative autoradiography for 5-HT1a and 5-HT2 receptors, Journal of the Neurological Sciences, vol.139, pp.83-90, 1996.
DOI : 10.1016/0022-510X(96)00109-8

E. Sofic, P. Riederer, W. Gsell, M. Gavranovic, and A. Schmidtke, Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis, Journal of Neural Transmission - Parkinson's Disease and Dementia Section, vol.38, issue.2, pp.133-142, 1991.
DOI : 10.1007/BF02260888

M. Turner, E. Rabiner, A. Hammers, A. Chalabi, and P. Grasby, [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS, Brain, vol.128, issue.4, pp.896-905, 2005.
DOI : 10.1093/brain/awh428

K. Lesch, B. Wolozin, D. Murphy, and P. Reiderer, Primary Structure of the Human Platelet Serotonin Uptake Site: Identity with the Brain Serotonin Transporter, Journal of Neurochemistry, vol.15, issue.6, pp.2319-2322, 1993.
DOI : 10.1016/0165-6147(92)90133-Q

S. Ramamoorthy, A. Bauman, K. Moore, H. Han, and T. Yang-feng, Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization., Proceedings of the National Academy of Sciences, vol.90, issue.6, pp.2542-2546, 1993.
DOI : 10.1073/pnas.90.6.2542
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC46124

J. Alvarez, D. Cremniter, P. Lesieur, A. Gregoire, and A. Gilton, Low blood cholesterol and low platelet serotonin levels in violent suicide attempters, Biological Psychiatry, vol.45, issue.8, pp.1066-1069, 1999.
DOI : 10.1016/S0006-3223(98)00160-7

J. Alvarez, N. Gluck, I. Arnulf, P. Quintin, and M. Leboyer, Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine, Clinical Pharmacology & Therapeutics, vol.66, issue.6, pp.617-624, 1999.
DOI : 10.1053/cp.1999.v66.103402001

D. Muck-seler, P. Presecki, N. Mimica, M. Mustapic, and N. Pivac, Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.33, issue.7, pp.1226-1231, 2009.
DOI : 10.1016/j.pnpbp.2009.07.004

E. Huey, K. Putnam, and J. Grafman, A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia, Neurology, vol.66, issue.1, pp.17-22, 2006.
DOI : 10.1212/01.wnl.0000191304.55196.4d

M. Strong, The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis, vol.4, issue.6, pp.323-338, 2008.
DOI : 10.1038/nature05016

M. Owens and C. Nemeroff, Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter, Clin Chem, vol.40, pp.288-295, 1994.

J. Csernansky and Y. Sheline, Abnormalities of Serotonin Metabolism and Nonpsychotic Psychiatric Disorders, Annals of Clinical Psychiatry, vol.5, issue.4, pp.275-281, 1993.
DOI : 10.3109/10401239309148828

O. Spreux-varoquaux, J. Alvarez, I. Berlin, G. Batista, and P. Despierre, Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters Relationships with impulsivity and depression, Life Sciences, vol.69, issue.6, pp.647-657, 2001.
DOI : 10.1016/S0024-3205(01)01158-4

T. Hillemacher, E. Grassel, S. Tigges, S. Bleich, and B. Neundorfer, Depression and bulbar involvement in amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol.22, issue.1, pp.245-249, 2004.
DOI : 10.1080/14660820410021294

E. Mcdonald, S. Wiedenfeld, A. Hillel, C. Carpenter, and R. Walter, Survival in Amyotrophic Lateral Sclerosis, Archives of Neurology, vol.51, issue.1, pp.17-23, 1994.
DOI : 10.1001/archneur.1994.00540130027010

C. Paillisse, L. Lacomblez, M. Dib, G. Bensimon, and S. Garcia-acosta, Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole, Amyotrophic Lateral Sclerosis, vol.5, issue.1, pp.37-44, 2005.
DOI : 10.1212/WNL.56.7.843

P. Guicheney, Human platelet serotonin content: methodological aspects and physiological variations, Methods Find Exp Clin Pharmacol, vol.10, pp.253-258, 1988.

A. Chio, G. Logroscino, O. Hardiman, R. Swingler, and D. Mitchell, Prognostic factors in ALS: A critical review, Amyotrophic Lateral Sclerosis, vol.330, issue.5-6, pp.310-323, 2009.
DOI : 10.1111/j.1600-0404.2004.00362.x
URL : https://hal.archives-ouvertes.fr/hal-00603350

E. Flachaire, C. Beney, A. Berthier, J. Salandre, and C. Quincy, Determination of reference values for serotonin concentration in platelets of healthy newborns, children, adults, and elderly subjects by HPLC with electrochemical detection, Clin Chem, vol.36, pp.2117-2120, 1990.

B. Turner, E. Lopes, and S. Cheema, The serotonin precursor 5???hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol.566, issue.8341, pp.171-176, 2003.
DOI : 10.1080/14660820310009389

E. Dunkley, G. Isbister, D. Sibbritt, A. Dawson, and I. Whyte, The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity, QJM, vol.96, issue.9, pp.635-642, 2003.
DOI : 10.1093/qjmed/hcg109

L. Tecott, Serotonin and the Orchestration of Energy Balance, Cell Metabolism, vol.6, issue.5, pp.352-361, 2007.
DOI : 10.1016/j.cmet.2007.09.012

L. Dupuis, H. Oudart, R. F. Gonzalez-de-aguilar, J. Loeffler, and J. , Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model, Proceedings of the National Academy of Sciences, vol.101, issue.30, pp.11159-11164, 2004.
DOI : 10.1073/pnas.0402026101

V. Yadav, F. Oury, N. Suda, Z. Liu, and X. Gao, A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure, Cell, vol.138, issue.5, pp.976-989, 2009.
DOI : 10.1016/j.cell.2009.06.051

L. Lacomblez, V. Doppler, I. Beucler, G. Costes, and F. Salachas, APOE: A potential marker of disease progression in ALS, Neurology, vol.58, issue.7, pp.1112-1114, 2002.
DOI : 10.1212/WNL.58.7.1112

J. Landers, J. Melki, V. Meininger, J. Glass, . Van-den et al., Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis, Proceedings of the National Academy of Sciences, vol.106, issue.22, pp.9004-9009, 2009.
DOI : 10.1073/pnas.0812937106

S. Sussmuth, A. Sperfeld, A. Hinz, J. Brettschneider, and S. Endruhn, CSF glial markers correlate with survival in amyotrophic lateral sclerosis, Neurology, vol.74, issue.12, pp.982-987
DOI : 10.1212/WNL.0b013e3181d5dc3b

J. Alvarez, N. Gluck, A. Fallet, A. Gregoire, and J. Chevalier, Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?, Psychopharmacology, vol.143, issue.1, pp.97-101, 1999.
DOI : 10.1007/s002130050924

F. Radat, I. Berlin, O. Spreux-varoquaux, S. Elatki, and M. Ferreri, Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression, Psychopharmacology, vol.127, issue.4, pp.370-376, 1996.
DOI : 10.1007/s002130050100